Partner Headlines - FOLD

  1. Mid-Morning Market Update: Markets Gain; Finish Line Beats Q1 ...

    Benzinga
  2. Morning Market Gainers

    Benzinga
  3. Keep An Eye On These 10 After-Hours Movers

    Benzinga
  4. Pier 1, BioMarin, HomeAway & Oracle Lead Wednesday's After-Hours ...

    Benzinga
  5. Benzinga's Volume Movers

    Benzinga
  6. US Stock Futures Surge Ahead Of ADP Report, Beige Book

    Benzinga
  7. Amicus Therapeutics Submits Marketing Authorization Application ...

    Benzinga
  8. US Stock Futures Jump Ahead Of Wholesale Inventories Data

    Benzinga
  9. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  10. Morning Market Gainers

    Benzinga
  11. Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday ...

    Benzinga
  12. Benzinga's Top #PreMarket Gainers

    Benzinga
  13. NPS Pharmaceuticals Spikes 19% Amid Shire Bid Report

    Benzinga
  14. These 4 Biotech Stocks Have Been On Fire

    Benzinga
  15. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD
  16. Benzinga's Top #PreMarket Losers

    Benzinga
  17. Mid-Day Losers From November 18: Omega Protein, Urban Outfitters, ...

    Benzinga
  18. Mid-Afternoon Market Update: Tyson Rises After Q4 Results; DreamWorks ...

    Benzinga
  19. Mid-Day Market Update: Allergan Jumps On Actavis Bid; Denbury ...

    Benzinga
  20. Midday Gainers From November 17: Celldex Therapeutics, Amicus ...

    Benzinga
  21. Mid-Morning Market Update: Markets Edge Lower; Halliburton To ...

    Benzinga
  22. Morning Market Movers

    Benzinga
  23. Benzinga's Top #PreMarket Gainers

    Benzinga
  24. Top 5 Biotech Stocks Over The Past Year

    Benzinga
  25. 3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, ...

    Benzinga
  26. Top 5 Performing Biotech Stocks Of 2014

    Benzinga
  27. Morning Market Movers

    Benzinga
  28. The Biotech Stock With The Best One-Week Performance

    Benzinga
  29. Stocks Hitting 52-Week Highs

    Benzinga
  30. Morning Market Movers

    Benzinga
  31. Benzinga's Top #PreMarket Gainers

    Benzinga
  32. Morning Market Movers

    Benzinga
  33. Amicus Extending Rally On Upgrades

    Benzinga
  34. Benzinga's Top Upgrades

    Benzinga
  35. Benzinga's Top #PreMarket Gainers

    Benzinga
  36. Morning Market Movers

    Benzinga
  37. Benzinga's Top #PreMarket Gainers

    Benzinga
  38. Earnings Scheduled For March 3, 2014

    Benzinga
  39. UPDATE: J.P. Morgan Downgrades Amicus Therapeutics On Cautious ...

    Benzinga
  40. Gilead Sciences Leads In Rising Short Interest Among Biotechs ...

    Benzinga
  41. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics ...

    Benzinga
  42. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, ...

    Benzinga
  43. Amicus, Biogen Announce Deal for Discovery, Development, Commercialization ...

    Benzinga
  44. Amicus Therapeutics Says Added 6-Month Results from Phase 3 Fabry ...

    Benzinga
  45. Amicus Therapeutics Advances Chaperone-ERT Combo Platform in ...

    Benzinga
  46. Amicus Announces Positive Phase 2 Results for Chaperone-Enzyme ...

    Benzinga
  47. Stocks Hitting 52-Week Lows

    Benzinga
  48. UPDATE: Wedbush Downgrades Amicus Therapeutics to Underperform ...

    Benzinga
  49. Option Traders Call a Bottom for Amicus Therapeutics

    SchaeffersResearch
  50. GlaxoSmithKline

    IBD
  51. Amicus, Glaxo Release Top-Line Six-Month Primary Treatment Period ...

    Benzinga
  52. Amicus Therapeutics Announces Additional Preliminary Results ...

    Benzinga
  53. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-Q)

    GuruFocus
  54. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-Q)

    GuruFocus
  55. UPDATE: Canaccord Reiterates Buy Rating, Raises PT on Amicus ...

    Benzinga
  56. Amylin Pharmaceuticals, Best Buy Among Stocks Up on High Volume ...

    FoxBusiness
  57. Benzinga's Top Upgrades with Color for May 8, 2012

    Benzinga
  58. UPDATE: J.P. Morgan Upgrades Amicus Therapeutics

    Benzinga
  59. From Earlier: Amicus Therapeutics Prices Underwritten Offering ...

    Benzinga
  60. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-K)

    GuruFocus
  61. Amicus Therapeutics Presents Preclinical Studies of Chaperone ...

    Benzinga
  62. Amicus Therapeutics Announces Positive Preliminary Results From ...

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!